General Hospital Psychiatry
Volume 32, Issue 4 , Pages 413-418 , July 2010

Predictors of pain intensity and pain functioning in patients with the hepatitis C virus

  • Benjamin J. Morasco, Ph.D.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    • Corresponding Author InformationCorresponding author. Portland VA Medical Center (R&D99), 3710 SW US Veterans Hospital Road, Portland, OR 97239, USA.
    • ,
  • Marilyn Huckans, Ph.D.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    • Research Division, Portland VA Medical Center, Portland, OR, USA
    • ,
  • Jennifer M. Loftis, Ph.D.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    • Research Division, Portland VA Medical Center, Portland, OR, USA
    • ,
  • Jonathan Woodhouse, Psy.D.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychology, George Fox University, Newberg, OR, USA
    • Dr. Woodhouse is now affiliated with the Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
    • ,
  • Adriana Seelye, M.S.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychology, Washington State University, Pullman, WA, USA
    • ,
  • Dennis C. Turk, Ph.D.

      Affiliations

    • Department of Anesthesiology and Pain Medicine, University of Washington School of Medicine, Seattle, WA, USA
    • ,
  • Peter Hauser, M.D.

      Affiliations

    • Northwest Hepatitis C Resource Center and Mental Health and Clinical Neurosciences Division, Portland VA Medical Center, Portland, OR 97239, USA
    • Department of Psychiatry, Oregon Health and Science University, Portland, OR, USA
    • Research Division, Portland VA Medical Center, Portland, OR, USA
    • Dr. Hauser is now affiliated with the Desert Pacific Healthcare Network Office, Long Beach, CA, USA.

Received 3 December 2009 ,Accepted 26 March 2010.

References 

  1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA. The prevalence of hepatitis C virus infection in the United States, 1998 through 1994. N Engl J Med. 1999;341:556–562
  2. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705–714
  3. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41–52
  4. Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol. 1999;94:1355–1360
  5. Rivera J, DeDiego A, Trinchet M, Monforte AG. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol. 1997;36:981–985
  6. Goulding C, O'Connell P, Murray FE. Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol. 2001;13:507–511
  7. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum. 1999;42:2204–2212
  8. Silberbogen AK, Janke EA, Hebenstreit CA. Closer look at pain and hepatitis C: preliminary data from a veteran population. J Rehabil Res Dev. 2007;44:231–244
  9. Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Opioid analgesic prescription use in veterans with hepatitis C. J Pain Symptom Manage. 2008;36:39–45
  10. Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Curr Pain Headache Rep. 2003;7:342–347
  11. Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19:53–62
  12. Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain. Pain. 2005;113:340–346
  13. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378
  14. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology. 1997;26:2S–10S
  15. Coury-Cautilena C, Van Raden M, Gibble J, et al. Routes of infection, viremia, and liver disease in asymptomatic individuals with hepatitis C virus infection. New Engl J Med. 1996;334:1691–1696
  16. El-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123:476–482
  17. Huckans MS, Blackwell AD, Harms TA, Indest DW, Hauser P. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS. 2005;(Suppl 3):S106–S115
  18. Fireman M, Indest DW, Blackwell A, Whitehead AJ, Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis. 2005;15:S286–S291
  19. Nelligan JA, Loftis JM, Matthews AM, Zucker BL, Linke AM, Hauser P. Depression comorbidity and antidepressant use in veterans with chronic hepatitis C: results from a retrospective chart review. J Clin Psychiatry. 2008;69:810–816
  20. Demyttenaere K, Bruffaerts R, Lee S, et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain. 2007;129:332–342
  21. Tunks ER, Crook J, Weir R. Epidemiology of chronic pain with psychological comorbidity: prevalence, risk, course, and prognosis. Can J Psychiatry. 2008;53:224–234
  22. Riley TR. Predictors of pain medication use after percutaneous liver biopsy. Dig Dis Sci. 2002;10:2151–2153
  23. Riley TR, Koch K. Characteristics of upper abdominal pain in those with chronic liver disease. Dig Dis Sci. 2003;10:1914–1918
  24. Huckans M, Seelye A, Parcel T, et al. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc. 2009;15:69–82
  25. Lackner C, Struber G, Liegl B, et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatol. 2005;41:1376–1382
  26. Wai C, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatol. 2003;38:518–526
  27. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity. A comparison of six methods. Pain. 1986;27:117–126
  28. Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston, MA: The Health Institute, New England Medical Center; 1994;
  29. Beck AT, Steer RA, Brown GK. Beck Depression Inventory Manual. 2nd ed. New York: Psychological Corporation; 1996;
  30. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine, and amphetamine users. Addiction. 1995;90:607–614
  31. Veterans Integrated Service Network-20 Data Warehouse. http://moss.v20.med.va.gov/v20dw/default.aspx.2005;Accessed 7/30/08
  32. Marcus DA. Obesity and the impact of chronic pain. Clin J Pain. 2004;20:186–191
  33. Jalkanen L, Tuomilehto J, Tanskanen A, Puska P. Accuracy of self-reported body weight compared to measured body weight: a population survey. Scan J Soc Med. 1987;15:191–198
  34. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. JAMA. 1998;280:147–151
  35. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002;23:131–137
  36. Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry. 2003;54:399–409
  37. Gatchel RJ, Peng YB, Peters ML, Fuchs PN, Turk DC. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol Bull. 2007;133:581–624
  38. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull. 1996;119:95–110
  39. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain: a review. Clin J Pain. 1997;13:116–137
  40. Hilsabeck RC, Hassanein TI, Perry W. Biopsychosocial predictors of fatigue in chronic hepatitis C. J Psychosom Res. 2005;58:173–178
  41. Banks SE, Riley TR, Naides SJ. Musculoskeletal complaints and serum autoantibodies associated with chronic hepatitis C and nonalcoholic fatty liver disease. Dig Dis Sci. 2007;52:1177–1182
  42. Shaheen AAM, Myers RP. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology. 2007;46:912–921

☆ This study was supported in part by a VA Career Development Award and Northwest Health Foundation grant awarded to Dr. Huckans. Dr. Morasco was supported by award K23DA023467 from the National Institute on Drug Abuse. The content of this manuscript is the responsibility of the authors and does not necessarily represent the official views of the Department of Veterans Affairs or the National Institute on Drug Abuse.

PII: S0163-8343(10)00060-5

doi: 10.1016/j.genhosppsych.2010.03.010

General Hospital Psychiatry
Volume 32, Issue 4 , Pages 413-418 , July 2010

Article Tools